Aramchol is an investigational drug being developed by Galmed Pharmaceuticals as a first-in-class, potentially treatment for nonalcoholic steatohepatitis,(NASH), a progressive form of non-alcoholic fatty liver disease. It is a conjugate of cholic acid and arachidic acid, and belongs to a class of synthetic fatty-acid/bile-acid conjugates(FABACs), which are composed of endogenous compounds administrated orally, with the aim of good safety and tolerability parameters.
Aramchol is an investigational drug being developed by Galmed Pharmaceuticals as a first-in-class, potentially treatment for nonalcoholic steatohepatitis,(NASH), a progressive form of non-alcoholic fatty liver disease. It is a conjugate of cholic acid and arachidic acid, and belongs to a class of synthetic fatty-acid/bile-acid conjugates(FABACs), which are composed of endogenous compounds administrated orally, with the aim of good safety and tolerability parameters.
Source: Wikipedia "Aramchol" · CC BY-SA 4.0
Share this article: X · Bluesky